首页>
外国专利>
COMPOSITION FOR PREVENTION AND TREATMENT OF HIV-1 INFECTION COMPRISING AT LEAST TWO DIFFERENT HIV-1 REVERSE TRANSCRIPTASE INHIBITORS
COMPOSITION FOR PREVENTION AND TREATMENT OF HIV-1 INFECTION COMPRISING AT LEAST TWO DIFFERENT HIV-1 REVERSE TRANSCRIPTASE INHIBITORS
展开▼
机译:预防和治疗至少两种不同的HIV-1逆转录酶抑制剂的HIV-1感染组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a composition for the prevention or treatment of HIV-1 infections which comprises a) a first HIV-1 reverse transcriptase inhibitor compound of formula (I) wherein X1 is oxygen or sulfur; Q is -C (R3) NOR4 or -COYR5; Yoxygen or sulfur; R1 is halogen; R2 is hydrogen, C1-4alkyl; R3 is hydrogen; R4 is C3-C6 alkyl; and R 5i) C 3-7 cycloalkyl optionally substituted with one or more C 1-4 alkyl groups; or ii) (a) a group of the general formula wherein R 6 is hydrogen or a straight or branched C 1-6 alkyl group; and R7 and R8 are hydrogen; and b) a second HIV-1 reverse transcriptase inhibitor compound that is not selected by the same one or more HIV-1 mutant strains as the first HIV-1 reverse transcriptase inhibitor compound of a); and the weight ratio of the first HIV-1 reverse transcriptase inhibitor compound to the second HIV-1 reverse transcriptase compound is between 100: 1 and 1: 100. ŕ
展开▼
机译:本发明提供了一种用于预防或治疗HIV-1感染的组合物,该组合物包括:a)第一种式(I)的HIV-1逆转录酶抑制剂化合物,其中X 1是氧或硫; Q是-C(R3)NOR4或-COYR5;氧或硫; R1是卤素; R 2是氢,C 1-4烷基; R3是氢; R4为C3-C6烷基; R 5i)任选地被一个或多个C 1-4烷基取代的C 3-7环烷基; ii)(a)具有通式的基团,其中R 6为氢或直链或支链的C 1-6烷基; R7和R8为氢; b)第二种HIV-1逆转录酶抑制剂化合物,该化合物不是由与a)的第一种HIV-1逆转录酶抑制剂化合物相同的一个或多个HIV-1突变株选择的;第一HIV-1逆转录酶抑制剂化合物与第二HIV-1逆转录酶化合物的重量比为100:1至1:100。
展开▼